N,N-Di(4-biphenylyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline>98.0%(HPLC)(T)1g

Benzyl 2-(5-bromo-1H-indole-3-carbonyl)pyrrolidine-1-carboxylate, 97%, 10g

(S)-2-((S)-2-AMINO-3-(4-HYDROXYPHENYL)PROPANAMIDO)PROPANOIC ACID, 98%, 100mg

Ethyl 3-(2-amino-2-oxoethoxy)pyrido[1,2-a]indole-10-carboxylate, 500mg

Ethyl 3,4-diethoxybenzoate, 97%, 1g

2,2,2-Trifluoro-1-(1,2,4,5-tetrahydro-7-nitro-1,5-methano-3H-3-benzazepin-3-yl)ethanone, 97%, 100mg

7-Bromo-5-methoxy-1H-indole, 98%, 100mg

1-(4-Trifluoromethyl-phenyl)-cyclobutanol, 98%, 100mg

Tinción de Leishman, 5 g

2,4-Dichloro-5-methylpyrimidine>98.0%(GC)5g

SALIRASIB, 97.0%, 25mg

2-(Trifluoromethyl)pyrimidin-5-ol, 97.0%, 10g

2-Amino-4-bromo-5-chlorophenol, 98.0%, 5g